Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Smoking damages key regulatory enzyme in the lung

07.09.2005


Smoking appears to reduce a key enzyme in the lungs, possibly contributing to some of smoking’s deleterious health effects, according to a study published in the September issue of the Journal of Nuclear Medicine. The study, which used a radiotracer to track the enzyme, also shows that smokers had a lower concentration of the tracer in the bloodstream than nonsmokers did, leading to speculation that smokers and nonsmokers may respond differently to a variety of substances administered by inhalation or intravenously, including therapeutic, anesthetic and addictive drugs.



“The effects of smoking on human health are enormous; yet, little is known about the pharmacologic effects of smoking on the human body apart from the effects of nicotine,” noted Joanna S. Fowler, Ph.D., program director of the Brookhaven Center for Translational Neuroimaging in Upton, N.Y. Researchers from Brookhaven National Laboratory, the National Institute on Drug Abuse and the State University of New York at Stony Brook used positron emission tomography (PET) scanning and a tracer chemical that binds to a specific form of the enzyme monoamine oxidase (MAO A) to track MAO A levels in both smokers and nonsmokers. With whole-body PET imaging, researchers could measure the concentration and movement of the radiotracer and MAO A, a subtype of the enzyme crucial to mood regulation and one that breaks down chemical compounds that elevate blood pressure, said the Society of Nuclear Medicine member.

In the study, “Comparison of Monoamine Oxidase A in Peripheral Organs in Nonsmokers and Smokers,” researchers traced the MAO A subtype in nine smokers and nine nonsmokers, discovering that MAO A was fairly well “intact” in all of the peripheral organs except in smokers’ lungs, said Fowler. Smokers had MAO A levels that were 50 percent lower than in nonsmokers, she said, noting that a prior study had also shown a significant reduction of MAO A in smokers’ brains.


MAO A breaks down many compounds that affect blood pressure, and the lung is a major metabolic organ in degrading some of these compounds, Fowler said. So reduced levels of MAO A in smokers’ lungs may be a significant factor contributing to some of the physiological effects of smoking, including changes in blood pressure and pulmonary function.

Smokers’ lungs also held onto the tracer chemical much longer than nonsmokers, and the delivery of tracer into the arterial blood supply was much lower for smokers, particularly for the first few minutes after being injected, Fowler added. This finding could imply that smokers and nonsmokers respond differently to other substances that enter the body via the bloodstream, including therapeutic drugs, anesthetics, abused substances and environmental agents—even nicotine.

Cigarette smoking, “the most damaging of all addictive substances,” remains the leading cause of preventable death and has negative health impacts on people at all stages of life, said Fowler, and has been in the headlines recently with the death of ABC “World News Tonight” anchorman Peter Jennings. Cigarette smoking accounts for 440,000 deaths each year in the United States, or nearly one of every five deaths, according to the Centers for Disease Control and Prevention. Smoking kills more Americans than AIDS, illegal drugs, alcohol, car accidents, suicides and murders combined and increases one’s chances of developing lung, bladder, esophageal and throat cancers; chronic lung diseases; and coronary heart and cardiovascular diseases.

Fowler and her colleagues have been studying MAO for more than 30 years. The U.S. Department of Energy (DOE) Office of Biological and Environmental Research and the National Institutes of Health have provided funding for this study, said Fowler. She added, “It’s important that the public know about the benefits derived from the DOE’s long-term investments in basic science—especially in radioisotope and radiotracer chemistry and imaging physics—that have played such an important role in introducing new nuclear medicine procedures into the practice of health care.”

“Comparison of Monoamine Oxidase A in Peripheral Organs in Nonsmokers and Smokers” appears in the September issue of the Journal of Nuclear Medicine, which is published by the Society of Nuclear Medicine. Fowler co-authored the article with Jean Logan, Ph.D., Colleen Shea, M.S., Victor Garza, M.S., Youwen Xu, M.S., Yu-Shin Ding, Ph.D., David Alexoff, BSE, and Donald Warner, all with Brookhaven National Laboratory’s chemistry department; Gene-Jack Wang, M.D., Frank Telang, M.D., Noelwah Netusil, RN, Pauline Carter, RN, Millard Jayne, RN, Payton King, M.S, and Paul Vaska, Ph.D., all with Brookhaven National Laboratory’s Medical Department; Nora D. Volkow, M.D., National Institute on Drug Abuse, Bethesda, Md.; Wei Zhu, Ph.D., Department of Applied Mathematics and Statistics, State University of New York at Stony Brook; and Dinko Franceschi, M.D., Department of Radiology, State University of New York at Stony Brook.

Maryann Verrillo | EurekAlert!
Further information:
http://www.snm.org

More articles from Life Sciences:

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>